Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Yu-hong Gan"'
Autor:
Feng Zhang, Shen-Xin Lu, Ke-Shu Hu, Yu-Hong Gan, Yi Chen, Ning-Lin Ge, Bi-Wei Yang, Lan Zhang, Rong-Xin Chen, Zheng-Gang Ren, Xin Yin
Publikováno v:
International Journal of Hyperthermia, Vol 38, Iss 1, Pp 1-10 (2021)
Objective Albumin-to-alkaline phosphatase ratio (AAPR), a newly developed blood biomarker, has been reported to have prognostic value in several types of cancer. This study aimed to investigate the predictive value of AAPR in patients with early-stag
Externí odkaz:
https://doaj.org/article/906b8ec935534ae1b09492e7a78a20a9
Autor:
Jing-huan Li, Xin Yin, Wen-shuai Fan, Lan Zhang, Rong-xin Chen, Yi Chen, Li-xin Li, Ning-ling Ge, Yu-hong Gan, Yan-hong Wang, Zheng-gang Ren
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundPatients with hepatocellular carcinoma (HCC) with main portal vein tumor thrombus (mPVTT) have poor prognosis. Promising systemic therapies, such as target therapies, have limited benefits. The purpose of this study is to retrospectively ev
Externí odkaz:
https://doaj.org/article/385a252f4b7d4f4db66afcf8993ab89e
Autor:
Zhenggang Ren, Sheng-Long Ye, Yi Chen, Jian-Feng Luo, Bo-Heng Zhang, Yan-Hong Wang, Yu-Hong Gan, Ning-Ling Ge, Rongxin Chen, Min Ma
Publikováno v:
Journal of Cancer
Purpose: The prognosis of patients with intermediate-stage hepatocellular carcinoma (HCC) treated by conventional TACE (cTACE) is greatly heterogeneous. This study aimed to develop a new survival prediction model to help select patients who would ben
Autor:
Shenxin Lu, Yi Chen, Xin Yin, Yu-Hong Gan, Zhenggang Ren, Rongxin Chen, Bi-wei Yang, Ning-lin Ge, Lan Zhang, Feng Zhang, Keshu Hu
Publikováno v:
International Journal of Hyperthermia, Vol 38, Iss 1, Pp 1-10 (2021)
Objective Albumin-to-alkaline phosphatase ratio (AAPR), a newly developed blood biomarker, has been reported to have prognostic value in several types of cancer. This study aimed to investigate the predictive value of AAPR in patients with early-stag
Publikováno v:
Journal of Clinical Oncology. 39:281-281
281 Background: TACE and lenvatinib has each shown to prolong overall survival in patients with unresectable HCC, combination of which may also improve clinical outcomes and have been widely used in the real world accordingly. However, the optimal ti
Publikováno v:
Journal of Clinical Oncology. 39:280-280
280 Background: Lenvatinib has become available as first-line therapy in patients with unresectable hepatocellular carcinoma (u-HCC). Although 8mg or 12mg/day is the standard starting dose according to weight, the high rate of adverse events (AEs) le
Autor:
Bo-heng Zhang, Yu-Hong Gan, Yan-Hong Wang, Rongxin Chen, Yan Wang, Zhenggang Ren, Sheng-long Ye, Yi Chen, Ning-lin Ge, Jian-Feng Luo, Hui Ma
Publikováno v:
Journal of Gastroenterology and Hepatology. 31:442-449
Background and Aim: Radiofrequency ablation (RFA) is recommended as one of the standard treatments for early hepatocellular carcinoma (HCC). Because of high-risk tumor locations unfit for RFA, transarterial chemoembolization (TACE) is served as an al
Autor:
Yu-Hong Gan, Jian-Feng Luo, W.-P. Wang, Zhenggang Ren, Y. Chen, Rongxin Chen, Ning-Ling Ge, Hong Ding, W. Kong
Publikováno v:
Clinical Radiology. 74:814.e1-814.e7
To evaluate whether elastic (stiffness) characteristics of tumours were associated with treatment responses and survival of patients with hepatocellular carcinoma (HCC) treated with transarterial chemoembolisation (TACE).A retrospective cohort study
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 15:4795-4800
Background: Few studies have directly compared clinical efficacy and safety among Chinese herb injections (CHIs) for gastric cancer (GC). The present study aimed to compare CHIs combined with FOLFOX regimens for GC to show which provides the best CHI
Autor:
Yan-Hong Wang, Bo-Heng Zhang, Bei Tang, Yan Wang, Zhenggang Ren, Hui Ma, Ning-Ling Ge, Sheng-Long Ye, Lan Zhang, Yu-Hong Gan, Rongxin Chen, Yi Chen
Publikováno v:
Annals of Surgical Oncology. 21:3084-3089
Serum γ-glutamyltranspeptidase (GGT) level, which is often elevated in hepatocellular carcinoma (HCC), has now been found to be an oxidative stress marker which correlates with inflammation in the extracellular hepatic microenvironment. The aim of t